Search

1 to 10 of 473
Sort by

Library Entry
A rare population of tumor antigen-specific CD4+CD8+ double-positive αβ T lymphocytes uniquely provide CD8-independent TCR genes for engineering therapeutic T cells

Published in the Journal for ImmunoTherapy of Cancer (JITC), is a research article that describes the discovery of a naturally occurring T-cell clone which expressed high-affinity HLA-A*02:01 (A*02)-restricted TCR against NY-ESO-1 from a patient who had NY-ESO-1-expressing ovarian tumor. ...


Library Entry
Cutaneous adverse reactions in B-RAF positive metastatic melanoma following sequential treatment with B-RAF/MEK inhibitors and immune checkpoint blockade or vice versa. A single-institutional case-se

Published in the Journal for ImmunoTherapy of Cancer (JITC), is a case report on patients treated with immune-checkpoint blockade followed by targeted therapy, or vice versa, who experienced cutaneous toxicities with unique histological patterns, a feature that has not been well described in...


Library Entry
Advances in Cancer Immunotherapy™ Webinar Series - Updates from the Field: ESMO Congress Clinical Trials Recording

This webinar provided an update on developments in the field relating to content presented at the Advances in Cancer Immunotherapy programs and focused on applicable information for a clinical audience. More specifically, program organizers Theodore F. Logan, MD, and David F. McDermott, MD,...



Library Entry
Nature of coexisting thyroid autoimmune disease determines success or failure of tumor immunity in thyroid cancer

Published in the Journal for ImmunoTherapy of Cancer (JITC), is a research article where researchers investigated the roles of humoral and cellular autoimmunity in the development of thyroid cancer and the likelihood of less aggressive behavior in the setting of Graves disease, combining...



Library Entry
Complete response of metastatic melanoma in a patient with Crohn’s disease simultaneously receiving anti-α4β7 and anti-PD1 antibodies

Published in the Journal for ImmunoTherapy of Cancer (JITC), is a case report of a man with Crohn’s disease actively requiring immunosuppressive therapy who subsequently received pembrolizumab for metastatic melanoma. Authors: Christopher C. Frohne , Ernesto M. Llano , Ashley Perkovic , ...


Library Entry
Infliximab for treatment-refractory transverse myelitis following immune therapy and radiation

Published in the Journal for ImmunoTherapy of Cancer (JITC), is a case report of a 68-year-old with metastatic melanoma, who developed transverse myelitis in the setting of immune checkpoint blockade and spinal irradiation for vertebral metastases. Authors: Victoria A. Chang , Daniel R....


Library Entry
Taking the bull by the horn: the frontline use of infliximab for the treatment of immune checkpoint inhibitor-induced enterocolitis

Published in the Journal for ImmunoTherapy of Cancer (JITC), is a commentary that provides a narrative summary of their findings in light of the current clinical knowledge relevant to the understanding of immune-related enterocolitis. Author: Khashayar Esfahani JITC(2018) 6:154 #Article ...


Library Entry
PI3Kα/δ inhibition promotes anti-tumor immunity through direct enhancement of effector CD8+ T-cell activity

Published in the Journal for ImmunoTherapy of Cancer (JITC), is a research article that examines the differential effects of AZD8835, a dual PI3Kα/δ inhibitor, specifically on the tumor immune microenvironment using syngeneic models. Authors: Larissa S. Carnevalli , Charles Sinclair , ...